Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5123
Abstract: Lenvatinib is approved for the treatment of patients with metastatic or recurrent hepatocellular carcinoma (HCC); however, clinical outcomes of lenvatinib therapy in patients with post‐liver transplantation (LT) HCC recurrence remain unclear. We investigated the efficacy… read more here.
Keywords: hepatocellular carcinoma; safety lenvatinib; lenvatinib; recurrent hepatocellular ... See more keywords
Efficacy and safety of lenvatinib in an elderly patient with metastatic papillary thyroid carcinoma and cardiological comorbidity: a case report.
Sign Up to like & getrecommendations! Published in 2019 at "Future oncology"
DOI: 10.2217/fon-2019-0114
Abstract: Lenvatinib significantly prolonged progression-free survival versus placebo in patients with radio-iodine refractory differentiated thyroid carcinoma. However, the primary adverse effects of any grade that occurred in >40% of patients in the lenvatinib group of the… read more here.
Keywords: carcinoma; lenvatinib elderly; efficacy safety; case ... See more keywords